Peter K Kaiser (Peter Kaiser)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 18

Top Topics

Vascular Endothelial Growth Factor

Systematic Review

Age Related Macular Degeneration

Top Venues

Eye (London, England)

Ophthalmology and therapy

BMJ open ophthalmology

Journal of ophthalmology

This page only lists publications with an associated author ORCID identifier.

Publications

Keean Nanji, Jim Xie, Amin Hatamnejad, Daiana R Pur, Mark Phillips, Dena Zeraatkar, Tien-Yin Wong, Robyn H Guymer, Peter K Kaiser, Sobha Sivaprasad, Mohit Bhandari, David H Steel, Charles C Wykoff, Varun Chaudhary
Exploring the fragility of meta-analyses in ophthalmology: a systematic review. Eye (London, England) (2024)
Ashish Sharma, Peter K Kaiser, Ramin Tadayoni, Frank G Holz, Luke Nicholson, Clara Vazquez-Alfageme, Sobha Sivaprasad, Taku Wakabayashi, Se Joon Woo, David Sarraf, Nilesh Kumar, Nikulaa Parachuri, Carl D Regillo, Kourous A Rezaei, Arshad M Khanani, Francesco Maria Bandello, Mahesh Shanamugam, Lalit Verma, Mangat Ram Dogra, Muralidhar Ns, Manisha Agarwal, Anat Loewenstein, Baruch D Kuppermann, null null
Anti-VEGF Biosimilars for Retinal Diseases Survey 2023- India (Bio-INDAS) by the International Retina Biosimilar Study Group (Inter-BIOS Group) in collaboration with the Vitreo-Retinal Society of India (VRSI). Eye (London, England) (2024)
Ashish Sharma, Peter K Kaiser, Ramin Tadayoni, Frank G Holz, Luke Nicholson, Clara Vazquez-Alfageme, Sobha Sivaprasad, Taku Wakabayashi, Se Joon Woo, David Sarraf, Nilesh Kumar, Nikulaa Parachuri, Carl D Regillo, Kourous A Rezaei, Arshad M Khanani, Francesco Maria Bandello, Mahesh Shanamugam, Lalit Verma, Mangat Ram Dogra, Muralidhar Ns, Manisha Agarwal, Anat Loewenstein, Baruch D Kuppermann, null null
Anti-VEGF Biosimilars for Retinal Diseases Survey 2023- India (Bio-INDAS) by the International Retina Biosimilar Study Group (Inter-BIOS Group) in collaboration with the Vitreo-Retinal Society of India (VRSI). Eye (London, England) (2024)
Peter K Kaiser, Jihoon Yun, Soyeon Kim, Jihyun Kim, Su Jin Park
Physicochemical and Biological Stability Assessment of SB11 (Ranibizumab Biosimilar) Under Ambient and In-Use Storage for Intravitreal Administration. Ophthalmology and therapy 12 (2) (2023)
Peter K Kaiser, Jihoon Yun, Soyeon Kim, Jihyun Kim, Su Jin Park
Physicochemical and Biological Stability Assessment of SB11 (Ranibizumab Biosimilar) Under Ambient and In-Use Storage for Intravitreal Administration. Ophthalmology and therapy 12 (2) (2023)
Peter K Kaiser, Jihoon Yun, Soyeon Kim, Jihyun Kim, Su Jin Park
Physicochemical and Biological Stability Assessment of SB11 (Ranibizumab Biosimilar) Under Ambient and In-Use Storage for Intravitreal Administration. Ophthalmology and therapy 12 (2) (2023)
Peter K Kaiser, Jihoon Yun, Soyeon Kim, Jihyun Kim, Su Jin Park
Physicochemical and Biological Stability Assessment of SB11 (Ranibizumab Biosimilar) Under Ambient and In-Use Storage for Intravitreal Administration. Ophthalmology and therapy (2023)
Peter K Kaiser, Paul M Karpecki, Carl D Regillo, Caroline Baumal, Edwin H Ryan, Michael S Ip, Yasha Modi, Elizabeth Yeu, Lisa Nijm, Marjan Farid, Ronald Luke Rebenitsch, Terry Kim, Diana L Shechtman, Kelly Nichols, Justin Schweitzer, Mark T Dunbar, Mohammad R Rafieetary, Eric D Donnenfeld
Geographic Atrophy Management Consensus (GA-MAC): a Delphi panel study on identification, diagnosis and treatment. BMJ open ophthalmology 8 (1) (2023)
Peter K Kaiser, Jihoon Yun, Soyeon Kim, Jihyun Kim, Su Jin Park
Physicochemical and Biological Stability Assessment of SB11 (Ranibizumab Biosimilar) Under Ambient and In-Use Storage for Intravitreal Administration. Ophthalmology and therapy 12 (2) (2023)
Mark R Phillips, Peter K Kaiser, Lehana Thabane, Mohit Bhandari, Varun Chaudhary, null null
Correction to: Risk of bias: why measure it, and how? Eye (London, England) (2022)
Anila Qasim, Tahira Devji, Mark R Phillips, Charles C Wykoff, Peter K Kaiser, Lehana Thabane, Mohit Bhandari, Varun Chaudhary, null null
Seeing the patient's perspective: a guide to patient-reported outcome measures and minimal important differences in ophthalmic research. Eye (London, England) 36 (7) (2022)
Arshad M Khanani, Mathew J Thomas, Aamir A Aziz, Christina Y Weng, Carl J Danzig, Glenn Yiu, Szilárd Kiss, Nadia K Waheed, Peter K Kaiser
Review of gene therapies for age-related macular degeneration. Eye (London, England) 36 (2) (2022)
Marc J Sirks, Elon H C Van Dijk, Noa Rosenberg, Carla E M Hollak, Stamatios Aslanis, Gemmy Cheung Chui Ming, Itay Chowers, Chiara M Eandi, K Bailey Freund, Frank G Holz, Peter K Kaiser, Andrew John Lotery, Kyoko Ohno-Matsui, Francesca Amoroso, Yousif Subhi, Ramin Tadayoni, Charles C Wykoff, Dinah Zur, Roselie M H Diederen, Camiel J F Boon, Reinier O Schlingemann
Clinical impact of the worldwide shortage of verteporfin (Visudyne®) on ophthalmic care. Acta ophthalmologica 100 (7) (2022)
Arshad M Khanani, Aamir A Aziz, Christina Y Weng, Weijie Violet Lin, Jordyn Vannavong, Jay Chhablani, Carl J Danzig, Peter K Kaiser
Port delivery system: a novel drug delivery platform to treat retinal diseases. Expert opinion on drug delivery 18 (11) (2021)
Mark R Phillips, Peter K Kaiser, Lehana Thabane, Mohit Bhandari, Varun Chaudhary, null null
Risk of bias: why measure it, and how? Eye (London, England) (2021)
Yimin Wang, Mengxi Shen, Jinwei Cheng, Xiaodong Sun, Peter K Kaiser
The Efficacy of Conbercept in Polypoidal Choroidal Vasculopathy: A Systematic Review. Journal of ophthalmology 2020 (2020)
Ashish Sharma, Nilesh Kumar, Nikulaa Parachuri, Srinivas R Sadda, Giulia Corradetti, Jeffrey Heier, Adam T Chin, David Boyer, Pouya Dayani, Sruthi Arepalli, Peter K Kaiser
Brolucizumab-early real-world experience: BREW study. Eye (London, England) 35 (4) (2020)
Peter K Kaiser, Laurent Kodjikian, Jean-Francois Korobelnik, Julia Winkler, Albert Torri, Oliver Zeitz, Robert Vitti, Cristiane Ahlers, Torsten Zimmermann, A Thomas Dicioccio, Joachim Höchel
Systemic pharmacokinetic/pharmacodynamic analysis of intravitreal aflibercept injection in patients with retinal diseases. BMJ open ophthalmology 4 (1) (2019)